SCHEMBL4983202

SCHEMBL4983202

COc1cc(=O)n(-c2ccccc2)cc1C.Cc1ccc(C(=O)O)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HPGD P15428 4/20 0.43
KDM4E B2RXH2 4/20 0.43
CYP1A2 P05177 1/20 0.43
BLM P54132 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 2/20 0.39
BRPF1 P55201 1/20 0.39
TP53 P04637 2/20 0.39
LMNA P02545 1/20 0.39
NOTUM Q6P988 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14215926 0.84 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ECYP1A2BLM
SCHEMBL14188927 0.81 ALDH1A1 (0.51) ALDH1A1HPGDKDM4ECYP1A2BLM
SCHEMBL6915576 0.72 CSNK2A1 (0.57) ALDH1A1KDM4EMEN1KMT2ANFE2L2
SCHEMBL6915656 0.72 CSNK2A1 (0.57) ALDH1A1KDM4EMEN1KMT2ANFE2L2
SCHEMBL4980883 0.72 MAPT (0.48) ALDH1A1HPGDKDM4EMAPTLMNA
SCHEMBL30679777 0.71 CSNK2A1 (0.59) ALDH1A1KDM4ETP53MEN1KMT2A
SCHEMBL107259 0.71 CSNK2A1 (0.59) ALDH1A1KDM4ETP53MEN1KMT2A
Bromide SCHEMBL6113400 0.69 CSNK2A1 (0.57) ALDH1A1KDM4EMEN1KMT2ANFE2L2
SCHEMBL6915580 0.69 CSNK2A1 (0.57) ALDH1A1KDM4EMEN1KMT2ANFE2L2
SCHEMBL6917296 0.69 CSNK2A1 (0.57) ALDH1A1KDM4EMEN1KMT2ANFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-05-22 US disclosed
EP-1847535-A1 1-(PIPERIDIN-4-YL)-1H-INDOLE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives TPH1, HTR1D, HTR1B ALDH1A1 91/4885HPGD 2392/4885KDM4E 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.